Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) saw a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 242,000 shares, an increase of 108.6% from the February 13th total of 116,000 shares. Based on an average daily volume of 1,350,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 5.5% of the company’s shares are sold short.
Analyst Ratings Changes
Separately, StockNews.com initiated coverage on shares of Check-Cap in a report on Sunday, March 9th. They issued a “sell” rating on the stock.
Read Our Latest Stock Analysis on CHEK
Check-Cap Trading Down 3.1 %
Check-Cap Company Profile
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Featured Articles
- Five stocks we like better than Check-Cap
- Technology Stocks Explained: Here’s What to Know About Tech
- How to Build the Ultimate Everything ETF Portfolio
- Why Invest in High-Yield Dividend Stocks?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Dividend Capture Strategy: What You Need to Know
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.